[
  {
    "ts": null,
    "headline": "Should J&J Stock Be in Your Portfolio After Q2 Beat & Guidance Raise?",
    "summary": "JNJ jumps over 6% on Q2 earnings beat and full-year guidance increase, driven by strong pharma sales and improved MedTech sales.",
    "url": "https://finnhub.io/api/news?id=c113eeba59047726891ebafe2e0c2fbd692e1e9a7c0afd2960e5f167c80b7e74",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753104960,
      "headline": "Should J&J Stock Be in Your Portfolio After Q2 Beat & Guidance Raise?",
      "id": 136025435,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "KVUE",
      "source": "Yahoo",
      "summary": "JNJ jumps over 6% on Q2 earnings beat and full-year guidance increase, driven by strong pharma sales and improved MedTech sales.",
      "url": "https://finnhub.io/api/news?id=c113eeba59047726891ebafe2e0c2fbd692e1e9a7c0afd2960e5f167c80b7e74"
    }
  },
  {
    "ts": null,
    "headline": "Oakmark Equity And Income Fund Q2 2025 Commentary",
    "summary": "Oakmark Equity And Income Fund Q2 2025 Commentary",
    "url": "https://finnhub.io/api/news?id=eac454cc13ccb0a29e2c0d39dc2d75ec9e86511d0275dd90feafff2b884e80f3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753073040,
      "headline": "Oakmark Equity And Income Fund Q2 2025 Commentary",
      "id": 136023368,
      "image": "",
      "related": "KVUE",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=eac454cc13ccb0a29e2c0d39dc2d75ec9e86511d0275dd90feafff2b884e80f3"
    }
  }
]